Prothena was founded in 2012 by distinguished scientists, Kathy and Kevin Blucher, and was built upon a strong heritage of small and large molecule drug discovery and development activities. As a result, Prothena has achieved many important milestones over the past few years and is now a global, clinical-stage biotechnology company.
